Vistin Pharma ASA: Invitation to Q2 2025 conference call
Oslo, Norway, 08 August 2025 Vistin Pharma ASA will release its second quarter and YTD 2025 results on Friday 15th...
Day: August 8, 2025
Coloplast A/S – 9M 2024/25 Earnings Release – Invitation to conference call on 19 August 2025 at 11.00am CEST
Tuesday, 19 August 2025 at 11.00 - 12.00h CESTIn connection with the publication of Coloplast’s interim financial results for 9M...
Sai Life Sciences Limited Reports Revenue growth of 77% YoY
Q1FY26 Revenue at ₹496 Cr; EBITDA at ₹125 Cr; Net Profit at ₹60 CrHYDERABAD, India, Aug. 08, 2025 (GLOBE NEWSWIRE)...
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update...
HK-listed IVD Medical Invests HK$149M in Ethereum through HashKey Exchange
HONG KONG, Aug. 8, 2025 /PRNewswire/ -- HashKey Exchange, Hong Kong's largest * licensed virtual asset trading platform, has entered...
RaySearch Laboratories: Interim report April – June 2025
STOCKHOLM, Aug. 8, 2025 /PRNewswire/ -- SECOND QUARTER (APRIL - JUNE 2025) Order intake amounted to SEK 241.2 M (290.3)Net...
SoftWriters Announces the Official Availability of a New Cloud-Based Business Insights and Analytics Platform, FrameworkInsight
Introducing FrameworkInsight: An Innovative Cloud-Based Business Intelligence Platform for Long-Term Care (LTC) Pharmacies PITTSBURGH, PA / ACCESS Newswire / August...
Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis
Dublin, Ireland--(Newsfile Corp. - August 8, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and...